Our experience of concurrent delay disputes in Kenya has shown the effectiveness of adopting a commonsense approach to assessing causation.
Continue readingKenya: Concurrent delay disputes and clear contractual provisions
Parallel imports remain a grey area for IP rights in East Africa
This prompted pharmaceutical lobbyists to voice concerns and the prohibition was received poorly among the Kenyan population.
Continue readingKenya: More options in financial distress
An important lesson learnt in this restructuring is that banks in Kenya are not excluded from the binding effect of schemes of arrangement.
Continue readingKenya: Pertinent legal issues in the protection of mobile apps
The increased use of smartphones have seen an increase in the use of mobile applications (mobile apps) worldwide.
Continue readingKenya: Healthy respect for advertising guidelines is critical in the pharmaceutical sector
In Kenya, regulation of the pharmaceutical industry is significantly more developed compared to regulation of other industries.
Continue readingKenya: Striking out of offensive company names
The Registrar has powers to compel a company to change its name if it is similar to another company’s name.
Continue reading